The House Energy and Commerce Committee today held a hearing on the administration’s progress in carrying out provisions of the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act, enacted last year to address the opioid epidemic. Lawmakers on both sides of the aisle criticized the Drug Enforcement Administration for delays in responding to committee inquiries about the agency’s enforcement of alleged “pill dumping” by manufacturers. Members also questioned federal agency heads about the higher cost of easily administered forms of opioid overdose reversal medicine, the percentage of addiction cases that are due to legally prescribed versus illegal drugs, and whether Congress should enact stronger criminal penalties for overprescribing of opioids. In a statement submitted to the committee, AHA recommended several federal actions to address the opioid crisis, including eliminating the Medicaid Institutions for Mental Disease exclusion for adults under age 65.

Related News Articles

Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Headline
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.